Anti-Human IDE Antibody (SAA1582)

Catalog No.

RHD06501

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

Insulysin, IDE, Abeta-degrading protease, Insulin protease, Insulinase, Insulin-degrading enzyme

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P14735

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA1582

High HBsAg Clearance Rate and Viral Dynamics in HBeAg-Positive, ALT-Normal Children and Adolescents with Chronic HBV Infection: Results from the Prospective Sprout Project., PMID:40469009

FDA Approval Summary: Idecabtagene Vicleucel for the Treatment of Triple-Class Exposed, Relapsed or Refractory Multiple Myeloma., PMID:40465403

Nanomaterial Enhances the Performance of Amyloid-beta Biosensing for Alzheimer's Disease Diagnosis., PMID:40337966

Drug development for chronic hepatitis B functional cure: Recent progress., PMID:40308829

Immune Checkpoint Inhibitor-induced Uveitis: Disproportionality and Timing Analyses of the Japanese Pharmacovigilance Database., PMID:40295055

Chronic Hepatitis B in the Transplant Setting: A 30-Year Experience in a Single Tertiary Italian Center., PMID:40284897

Impact of DTaP-IPV and DTaP Vaccination Among Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Prospective Observational Study., PMID:40266146

Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China., PMID:40206433

Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss., PMID:40108632

Liver transplantation for hepatitis D virus/hepatitis B virus coinfection in Italy: an intention-to-treat analysis of long-term outcomes., PMID:40057194

Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence., PMID:40041120

Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B., PMID:40008890

Dual-mode capacitive and localized surface plasmon resonance biosensor based on high-density Au nanoislands., PMID:39987657

Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay., PMID:39936124

Lipocalin-2 Determination on Multiwalled Carbon Nanotube Integrated Circular Electrodes for Diagnosing Ulcerative Colitis., PMID:39834132

Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study., PMID:39822585

Adult-onset hypophosphatasia diagnosed after consecutive tooth loss during orthodontic treatment: a case report., PMID:39702252

Rheumatoid factor levels indicate cryoglobulinemia severity in hepatitis B e antigen-negative hepatitis B virus carriers: a 7-year prospective cohort study., PMID:39699792

Achieving chronic hepatitis B functional cure: Factors and potential mechanisms., PMID:39662778

Immunogenicities of vaccines including the immunoglobulin M-degrading enzyme of Streptococcus suis, rIde Ssuis , and protective efficacy against serotype 14 in piglets., PMID:39659664

Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation., PMID:39638038

Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy., PMID:39632797

Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical Trials., PMID:39624922

Association of PIRCHE-II score with anti-donor T-cell response and risk of de novo donor-specific antibody production in kidney transplant recipients., PMID:39500398

Thiol-SAM Concentration Effect on the Performance of Interdigitated Electrode-Based Redox-Free Biosensors., PMID:39459128

COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production., PMID:39443853

IFN-γ and IL-10 Immunosensor with Vertically Aligned Carbon Nanotube Interdigitated Electrodes toward Pen-Side Cattle Paratuberculosis Monitoring., PMID:39440229

Limited Value of HBV-RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative Hepatitis B Patients., PMID:39425534

The impact of hepatitis B surface antigen seroconversion on the durability of functional cure induced by pegylated interferon alpha treatment., PMID:39363288

[Role of CAR-T in multiple myeloma and coordination between referring and treating centers]., PMID:39358259

Association of hepatitis B core antibody level and hepatitis B surface antigen clearance in HBeAg-negative patients with chronic hepatitis B., PMID:39317345

The immunoglobulin M-degrading enzyme of Streptococcus suis (IdeSsuis) leads to long-lasting inhibition of the activation of porcine IgM-secreting B cells., PMID:39313819

CAR-T cell therapy in relapsed or refractory multiple myeloma and access in Turkey., PMID:39267974

Gold-antibody-aptamer complexed electrochemical sensing surface for septic arthritis biomarker determination., PMID:39262996

Updates on CAR T cell therapy in multiple myeloma., PMID:39261906

Polymorphisms in genes involved in regulating follicular helper T cell differentiation predict de novo donor-specific antibody formation after liver transplantation., PMID:39255558

What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis., PMID:39206573

Evaluation of Anti-CAR Linker mAbs for CAR T Monitoring after BiTEs/bsAbs and CAR T-Cell Pretreatment., PMID:39200107

Efgartigimod Successfully Ameliorated Acute Exacerbation of Myasthenia Gravis with Anti-muscle-specific Kinase Antibodies., PMID:39111891

TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models., PMID:39109538

Fast and furious: Changing gears on the road to cure with chimeric antigen receptor T cells in multiple myeloma., PMID:39095225

Model-based population pharmacokinetic and exposure response analyses for safety and efficacy of nivolumab as adjuvant treatment in subjects with resected oesophageal or gastroesophageal junction cancer., PMID:39054780

Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis B., PMID:38992769

Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors., PMID:38983963

A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally suppressed patients with chronic hepatitis B who are HBeAg-negative., PMID:38976867

Current trends and advances in antiviral therapy for chronic hepatitis B., PMID:38945693

First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma., PMID:38906964

Large-area grown ultrathin molybdenum oxides for label-free sensitive biomarker detection., PMID:38887082

Risk of rituximab-induced hepatitis B flare after antiviral discontinuation in rheumatic patients with chronic hepatitis B virus., PMID:38855955

JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase., PMID:38772503

Document Download

Anti-Human IDE Antibody (SAA1582).pdf